Advisor Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$0 Hold
2019
Q3
$0 Hold
2019
Q2
$0 Hold
2019
Q1
$0 Sell
2018
Q4
$0 Hold
2018
Q3
$1K Buy
2018
Q2
$1K Hold
2018
Q1
$1K Hold
2017
Q4
$3K Buy